| Field | Specification |
|---|---|
| Target | |
| Antigen | |
| Alternative names | 2010305N14Rik; 2610318G18Rik; AI647667; damage regulated autophagy modulator 2; DNA damage regulated autophagy modulator 2; DNA damage regulated autophagy modulator protein 2; DNA damage-regulated autophagy modulator protein 2; Dram2; DRAM2_HUMAN; PRO180; PSEC0031; RP5-1180E21.1; Tmem77; Transmembrane protein 77; WWFQ154 |
| UniProt # | |
| Host | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | Recombinant Human DNA damage-regulated autophagy modulator protein 2 protein (182-266AA) |
| Conjugate | |
| Source | This product is a polyclonal antibody purified from rabbit antiserum. |
| Purification | |
| Form | Liquid |
| Storage | |
| Storage buffer | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
Primary AntibodyThis antibody targets DRAM2 and was raised against a recombinant protein immunogen.
Validated Applications
| Application | Recommended Dilution |
|---|---|
| ELISA | IHC:1:20-1:200, IF:1:50-1:200 |
| Immunohistochemistry (IHC) | IHC:1:20-1:200, IF:1:50-1:200 |
| Immunofluorescence (IF) | IHC:1:20-1:200, IF:1:50-1:200 |
Antibody Specifications
| Target | DRAM2 |
|---|---|
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugate | Unconjugated |
| Reactivity | Human |
| Purification | Affinity Purification |
| Antigen / Immunogen | Recombinant Human DNA damage-regulated autophagy modulator protein 2 protein (182-266AA) |
| Production | This product is a polyclonal antibody purified from rabbit antiserum. |
| Form | Liquid |
| Storage Buffer | PBS, 0.02% sodium azide, 50% glycerol, pH 7.3. |
| Storage | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
Alternative Names
2010305N14Rik; 2610318G18Rik; AI647667; damage regulated autophagy modulator 2; DNA damage regulated autophagy modulator 2; DNA damage regulated autophagy modulator protein 2; DNA damage-regulated autophagy modulator protein 2; Dram2; DRAM2_HUMAN; PRO180; PSEC0031; RP5-1180E21.1; Tmem77; Transmembrane protein 77; WWFQ154
Safety & Handling
| Target | DRAM2 |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugate | Unconjugated |
| Reactivity | Human |
| Purification | Affinity Purification |
| Antigen/Immunogen | Recombinant Human DNA damage-regulated autophagy modulator protein 2 protein (182-266AA) |
| Production | This product is a polyclonal antibody purified from rabbit antiserum. |
| Form | Liquid |
| Storage Buffer | PBS, 0.02% sodium azide, 50% glycerol, pH 7.3. |
| Storage | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
Dilutions are starting recommendations. Titration is advised for each system.
| Application | Recommended Dilution |
|---|---|
| ELISA | IHC:1:20-1:200, IF:1:50-1:200 |
| Immunohistochemistry (IHC) | IHC:1:20-1:200, IF:1:50-1:200 |
| Immunofluorescence (IF) | IHC:1:20-1:200, IF:1:50-1:200 |
Immunogen: Recombinant Human DNA damage-regulated autophagy modulator protein 2 protein (182-266AA)
Antigen Species: Human
Alternative Names
2010305N14Rik; 2610318G18Rik; AI647667; damage regulated autophagy modulator 2; DNA damage regulated autophagy modulator 2; DNA damage regulated autophagy modulator protein 2; DNA damage-regulated autophagy modulator protein 2; Dram2; DRAM2_HUMAN; PRO180; PSEC0031; RP5-1180E21.1; Tmem77; Transmembrane protein 77; WWFQ154
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
